Targeted immunosuppressant on trial for rheumatoid arthritis.
Bonn
D
D
D001172:Arthritis, Rheumatoid / Q000628:therapy*; D001324:Autoantigens / Q000276:immunology* / Q000378:metabolism; D017321:Clinical Trials, Phase I as Topic; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008285:Major Histocompatibility Complex / Q000276:immunology*; D010455:Peptides / Q000276:immunology* / Q000378:metabolism; D013601:T-Lymphocytes / Q000187:drug effects
D001324:Autoantigens; D006023:Glycoproteins; D007166:Immunosuppressive Agents; D010455:Peptides